Stockscreener 앱 받기
4.23
2.08%
-0.09
시간 외 거래:
4.24
0.010
+0.24%
전일 마감가:
$4.32
열려 있는:
$4.29
하루 거래량:
276.48K
Relative Volume:
0.24
시가총액:
$213.49M
수익:
-
순이익/손실:
$-147.71M
주가수익비율:
-1.1797
EPS:
-3.5857
순현금흐름:
$-127.89M
1주 성능:
-8.64%
1개월 성능:
+5.22%
6개월 성능:
-79.37%
1년 성능:
-79.19%
1일 변동 폭
$4.22
$4.36
1주일 범위
$4.22
$4.655
52주 변동 폭
$3.00
$25.45
Cargo Therapeutics Inc Stock (CRGX) Company Profile
명칭
Cargo Therapeutics Inc
전화
650-499-8950
주소
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
CRGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
4.23 | 213.49M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-30 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2025-01-30 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-01-30 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2025-01-30 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-01-30 | 다운그레이드 | Truist | Buy → Hold |
| 2025-01-30 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-11-26 | 개시 | William Blair | Outperform |
| 2024-07-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-08 | 개시 | Chardan Capital Markets | Buy |
| 2024-06-27 | 개시 | Piper Sandler | Overweight |
| 2023-12-05 | 개시 | JP Morgan | Overweight |
| 2023-12-05 | 개시 | Jefferies | Buy |
| 2023-12-05 | 개시 | TD Cowen | Outperform |
| 2023-12-05 | 개시 | Truist | Buy |
모두보기
Cargo Therapeutics Inc 주식(CRGX)의 최신 뉴스
Cargo Therapeutics stock rating cut by Jefferies to Hold - MSN
JPMorgan Chase & Co. Raises Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Prepare Yourself for Liftoff: CARGO Therapeutics Inc (CRGX) - Sete News
CARGO Therapeutics Inc (NASDAQ: CRGX): Can A Stock Be -68.31% Lower Year-To-Date And Still Be A Loser? - Marketing Sentinel
Legal & General Group Plc Trims Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Examining the Potential Price Growth of CARGO Therapeutics Inc (CRGX) - knoxdaily.com
Ratio Analysis: Unpacking CARGO Therapeutics Inc (CRGX)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Recent Insider Activity Could Benefit CARGO Therapeutics Inc (CRGX) - knoxdaily.com
What Has Been Going On With CARGO Therapeutics Inc (NASDAQ: CRGX) - Stocksregister
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Acquired by Geode Capital Management LLC - Defense World
CARGO Therapeutics Inc’s (NASDAQ: CRGX) Stock Price Will Be Bearish Or Bullish In 2025 - Stocksregister
CRGX: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Vanguard Group Inc. Purchases 22,286 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
American Century Companies Inc. Invests $474,000 in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Rating of “Reduce” from Analysts - Defense World
Cargo Therapeutics executive Anup Radhakrishnan sells $6,522 in stock By Investing.com - Investing.com South Africa
Trial misses sink cancer stocks in Q1: Mersana, Cargo, Mural fall - BioWorld MedTech
Cargo Therapeutics executive Anup Radhakrishnan sells $6,522 in stock - Investing.com
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Swiss National Bank Boosts Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Brokers Offer Predictions for CRGX FY2025 Earnings - Defense World
Is CARGO Therapeutics (NASDAQ:CRGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Biotech company based in Peninsula laying off 90% of staff - MSN
Finance Watch: Cargo Restructuring Not The News The IPO Market Needs - insights.citeline.com
California-Based Biotech Therapeutics Firm Lays Off 90% of Workforce - NewsBreak: Local News & Alerts
Fierce Biotech Layoff Tracker 2025: Cargo lays off 90% of staff; Empress halves workforce - Fierce Biotech
Bay Area biotech company laying off 90% of staff as CEO leaves - San Francisco Chronicle
Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff - SFGATE
CARGO THERAPEUTICS Earnings Preview: Recent $CRGX Insider Trading, Hedge Fund Activity, and More - Nasdaq
90% Workforce Reduction Sent This Small Cap Soaring - The Globe and Mail
CARGO Stock Surges 19% Pre-Market After Suspending Development, Cutting 90% of Workforce - GuruFocus.com
Cargo Therapeutics scraps R&D pipeline, axes bulk of workforce as it looks for an exit - Endpoints News
Cargo shelves cell therapy research, lays off more staff - BioPharma Dive
Cargo Lays Off 90% of Staff and Stops Development Work - BioSpace
CARGO Therapeutics (CRGX) Stock Climbs In Pre-Hour Market - Stocks Telegraph
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga
After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more - Investing.com
Once-high-flying Cargo Therapeutics looks to ditch remaining work as CEO exitsSan Francisco Business Times - The Business Journals
Cargo Therapeutics provides corporate update -March 18, 2025 at 05:43 pm EDT - Marketscreener.com
CARGO Therapeutics halts development, cuts 90% of staff By Investing.com - Investing.com Australia
CARGO Therapeutics rises after hours on workforce reduction - MSN
CARGO Therapeutics halts development, cuts 90% of staff - Investing.com
CARGO Therapeutics Announces Major Workforce Reduction - TipRanks
Cargo Therapeutics Inc (CRGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):